SCHEMBL6668543

SCHEMBL6668543

CCCCCCCCCCCCCC[N+](C)(CCO)CCCCCCCCCCCCCC.COS(=O)(=O)[O-]

nearest known ligand 0.47

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 9/20 0.47
PSMD14 O00487 2/20 0.45
PLA2G1B P04054 2/20 0.45
MMP2 P08253 2/20 0.45
ATG4B Q9Y4P1 2/20 0.45
RAD52 P43351 1/20 0.45
RECQL P46063 2/20 0.41
GLA P06280 1/20 0.41
HPGD P15428 1/20 0.41
TSHR P16473 1/20 0.41
MAPK1 P28482 1/20 0.41
EPHX2 P34913 1/20 0.41
BLM P54132 1/20 0.41
LSS P48449 1/20 0.38
HSP90AA1 P07900 1/20 0.38
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6669104 1.00 DNM1 (0.47) DNM1PSMD14PLA2G1BMMP2ATG4B
SCHEMBL11292693 1.00 DNM1 (0.47) DNM1PSMD14PLA2G1BMMP2ATG4B
SCHEMBL6672668 1.00 DNM1 (0.47) DNM1PSMD14PLA2G1BMMP2ATG4B
SCHEMBL2026336 1.00 DNM1 (0.47) DNM1PSMD14PLA2G1BMMP2ATG4B
SCHEMBL2469815 0.98 DNM1 (0.46) DNM1PSMD14PLA2G1BMMP2ATG4B
SCHEMBL28311626 0.94 DNM1 (0.44) DNM1PSMD14PLA2G1BMMP2ATG4B
SCHEMBL30954840 0.94 DNM1 (0.44) DNM1PSMD14PLA2G1BMMP2ATG4B
SCHEMBL29281610 0.94 DNM1 (0.44) DNM1PSMD14PLA2G1BMMP2ATG4B
SCHEMBL15140667 0.93 DNM1 (0.43) DNM1PSMD14PLA2G1BMMP2ATG4B
SCHEMBL27870214 0.92 DNM1 (0.42) DNM1PSMD14PLA2G1BMMP2ATG4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4640308-A1 ENVIRONMENTALLY BIODEGRADABLE COMPOSITIONS COMPRISING AN AMINO ACID ADDUCT, CONTROLLED RELEASE PARTICLES AND COMPOSITIONS COMPRISING SAME, AND METHODS OF MAKING SAME TRuCapSol LLC (US) 2025-10-29 EP disclosed
US-20250326882-A1 ENVIRONMENTALLY BIODEGRADABLE COMPOSITIONS COMPRISING AN AMINO ACID ADDUCT, CONTROLLED RELEASE PARTICLES AND COMPOSITIONS COMPRISING SAME, AND METHODS OF MAKING SAME TRUCAPSOL LLC (US) 2025-10-23 US disclosed
US-12187829-B2 Environmentally biodegradable microcapsules TRUCAPSOL LLC (US) 2025-01-07 US disclosed
US-11904288-B1 Environmentally biodegradable microcapsules TRUCAPSOL LLC (US) 2024-02-20 US disclosed
US-11878280-B2 Microcapsules comprising natural materials TRUCAPSOL LLC (US) 2024-01-23 US disclosed
EP-4265326-A2 MICROCAPSULES COMPRISING NATURAL MATERIALS TRuCapSol, LLC. (US) 2023-10-25 EP disclosed
US-11794161-B1 Reduced permeability microcapsules TRUCAPSOL, LLC (US) 2023-10-24 US disclosed
US-20230329982-A1 RESIN COMPOSITIONS COMPRISING A MACROMOLECULE CROSSLINKED WITH POLYAMIDE EPICHLOROHYDRIN, CONTROLLED RELEASE PARTICLES AND COMPOSITIONS COMPRISING SAME, AND METHODS OF MAKING SAME ALTER DOMUS (US) LLC 2023-10-19 US disclosed
US-20230330615-A1 MICROCAPSULES COMPRISING NATURAL MATERIALS ALTER DOMUS (US) LLC 2023-10-19 US disclosed
US-20230060181-A1 ENVIRONMENTALLY BIODEGRADABLE MICROCAPSULES ALTER DOMUS (US) LLC 2023-03-02 US disclosed
WO-2019173062-A1 REDUCED PERMEABILITY MICROCAPSULES TRUCAPSOL, LLC (US) 2019-09-12 WO disclosed
EP-1102836-B1 WATER-IN-OIL MICROEMULSION FOR PROVIDING COSMETIC ATTRIBUTES TO FABRIC SOFTENING BASE COMPOSITION COLGATE PALMOLIVE CO (US) 2004-09-22 EP disclosed
US-20040167058-A1 Multi-phase clear fabric softening composition COLGATE-PALMOLIVE COMPANY 2004-08-26 US disclosed
US-6620437-B2 Mixture containing perfumes COLGATE-PALMOLIVE CO. 2003-09-16 US disclosed
US-20020183227-A1 Multi-phase clear fabric softening composition ZWICKROELL GMBH & CO. KG (DE) 2002-12-05 US disclosed
US-6362158-B1 RADIATION TRANSPARENT COLGATE-PALMOLIVE CO. 2002-03-26 US disclosed
US-20020010104-A1 Water-in-oil microemulsion for providing cosmetic attributes to fabric softening base composition COLGATE-PALMOLIVE COMPANY 2002-01-24 US disclosed
EP-0801672-B1 CLEAR, CONCENTRATED LIQUID FABRIC SOFTENER COMPOSITIONS COLGATE PALMOLIVE CO (US) 2001-10-04 EP disclosed
US-5656585-A AQUEOUS MICROEMULSION CONCENTRATE COMPRISING DIESTER QUATERNARY AMMONIUM SURFACTANT FABRIC SOFTENER, DIAMIDO AMMONIUM SURFACTANT FABRIC SOFTENER, ORGANIC SOLVENT, OPTIONAL WATER IMMISCIBLE OIL PERFUME, CO-SOFTENER COLGATE-PALMOLIVE COMPANY (US) 1997-08-12 US disclosed
US-5525245-A CONTAINING DIESTER QUATERNARY AMMONIUM AND/OR DIAMIDE AMMONIUM SURFACTANT, ORGANIC SOLVENT, WATER, OPTIONAL PERFUME OIL, FATTY CO-SOFTENER COLGATE-PALMOLIVE COMPANY (US) 1996-06-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250326882-A1 ENVIRONMENTALLY BIODEGRADABLE COMPOSITIONS COMPRISING AN AMINO ACID ADDUCT, CONTROLLED RELEASE PARTICLES AND COMPOSITIONS COMPRISING SAME, AND METHODS OF MAKING SAME APEH, CD44, ATIC DNM1 4860/4885PSMD14 891/4885PLA2G1B 3801/4885
US-11878280-B2 Microcapsules comprising natural materials RCC1, SAMM50, LIPA DNM1 4803/4885PSMD14 2641/4885PLA2G1B 1946/4885
US-11794161-B1 Reduced permeability microcapsules CHMP4B, NSF, ACR DNM1 4496/4885PSMD14 387/4885PLA2G1B 1680/4885
US-20230330615-A1 MICROCAPSULES COMPRISING NATURAL MATERIALS RCC1, SAMM50, LIPA DNM1 4803/4885PSMD14 2641/4885PLA2G1B 1946/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.